November 5, 2010 – As part of the U.S. government’s Therapeutic Discovery Project, Orbital Therapy has been awarded nearly $250,000 for a breast cancer research project.
The company has successfully developed and tested its dedicated, self-shielded radiotherapy device for breast cancer treatment. The approach integrates the shielding directly into the machine’s design, eliminating the need for an expensive bunker. This allows the operator to remain in the room with the patient and protects the patient from unwanted radiation.
The grant was established to fuel the development of products that meet an unmet medical need to detect or treat chronic or acute diseases and conditions. The grant totaled $244,479.
“This will allow us to gather physics data from our working prototype and make accurate predictions of the benefits to the rest of the patient from being outside the high radiation zone, reducing the risk of radiation induced late effects,” said Alan Sliski, CTO of Orbital Therapy.
For more information: www.orbitaltherapy.com
April 25, 2024 
